BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2014
View Archived Issues
Celsion completes acquisition of EGEN
Read More
Merck KGaA to begin phase I trial of MSB-0010841 in patients with psoriasis
Read More
Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy
Read More
Scripps Research Institute and T23 sign license for CD22 siglec oncoimmunological platform
Read More
Inovio's INO-3112 enters phase I/IIa trial in cervical cancer
Read More
Ultra-long-acting LAPS-insulin well tolerated and active in type 1 and 2 diabetes
Read More
Phase II results reported for indisulam with idarubicin and cytarabine in myeloid malignancies
Read More
Results of phase I trial: pevonedistat in combination with azacitidine for AML
Read More
Dose-escalation study of mPEG-r-crisantaspase, a new PEGylated asparaginase
Read More
Phase I and expansion cohort results presented for a yeast-based therapeutic cancer vaccine
Read More
EDO-S101, a novel candidate for the treatment of multiple myeloma
Read More
Verona Pharma's VRP-700 misses endpoint in chronic cough trial
Read More
Bayer HealthCare and Dimension Therapeutics to develop novel gene therapy for hemophilia A
Read More
Living Cell Technologies resumes trial of encapsulated cell therapy in Parkinson's disease
Read More
XenoPort begins phase II trial of XP-23829 in patients with psoriasis
Read More
Genocea reports topline phase I data for universal pneumococcus vaccine candidate
Read More
EMA's COMP adopts positive opinion on marizomib in multiple myeloma
Read More
Akorn sells subsidiary to Valeant Pharmaceuticals
Read More
Trevena reports phase I results for TRV-734 in acute and chronic pain
Read More
Hangzhou Zylox Pharma discloses new rapamycin analogues
Read More
Boehringer Ingelheim decides not to pursue hepatitis C drug development
Read More
NovoMedix patents novel treatments for cancer and fibrosis
Read More
Kyowa Hakko Kirin patent reports new CCR10 receptor antagonists
Read More
Allergan board of directors rejects exchange offer from Valeant Pharmaceuticals
Read More
Scientists at Temple University prepare and test novel 5-HT2B antagonists
Read More
Sunovion Pharmaceuticals reports development of PDE10A inhibitors
Read More
Roche files IND to begin phase II study of Erivedge in IPF
Read More